Takeda Yakuhin Kogyo KK header image

Takeda Yakuhin Kogyo KK

TAK

Equity

ISIN null / Valor 11292411

New York Stock Exchange, Inc (2026-05-04)

USD 16.56-0.36%

Takeda Yakuhin Kogyo KK
UMushroom community rating:

5.00 2 votes No rating yet

NegativeNeutralPositive

About company

Takeda Yakuhin Kogyo K.K. is a Japanese pharmaceutical manufacturer that develops, produces and markets medicines and related chemical intermediates for healthcare markets, supplying hospitals, pharmacies and distributors at home and abroad. Its business combines research and formulation work with commercial manufacturing—covering active pharmaceutical ingredient production, finished‑dose formulation, quality control and regulatory compliance—and it also provides contract manufacturing and outsourcing services to other drugmakers. The company’s product mix spans prescription (ethical) medicines, consumer health/OTC products and bulk pharmaceutical ingredients, with operations organized to support manufacturing scale, supply‑chain reliability and customer distribution channels.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

8.09%1Y

-1.13%3Y

-0.30%5Y

Performance

20.8%1Y

19.1%3Y

19.5%5Y

Volatility

52316 M

Market cap (USD)

2,183,446

Daily traded volume (Shares)

13.25 / 13.155

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

5.00

2 votes

Performance:

4.00

Innovation:

3.00

Society:

3.00

Nature:

3.00

Adam Hakimi Bin Hasni

United Kingdom, 04 Nov 2025

A good company for long term investment as pharmaceutical and healthcare is a much needed service in Japan

sofia nava

Switzerland, 29 Oct 2025

.

EQUITIES OF THE SAME SECTOR

Elanco Animal Health Inc

Elanco Animal Health Inc Valor: 43127600

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 22.51

GSK PLC

GSK PLC Valor: 120042705

Annual Return

-50%0%+50%

Risk level

110

-1.38%USD 50.90

Laboratorios Farmaceuticos Rovi, SA

Laboratorios Farmaceuticos Rovi, SA Valor: 3591807

Annual Return

-50%0%+50%

Risk level

110

0.00%EUR 79.40

Almirall SA

Almirall SA Valor: 3180354

Annual Return

-50%0%+50%

Risk level

110

-2.07%EUR 12.32

Nelnet Inc

Nelnet Inc Valor: 1665235

Annual Return

-50%0%+50%

Risk level

110

-0.47%USD 140.99

Pharma Mar SA

Pharma Mar SA Valor: 56130572

Annual Return

-50%0%+50%

Risk level

110

5.52%EUR 101.30

Faes Farma SA

Faes Farma SA Valor: 2837976

Annual Return

-50%0%+50%

Risk level

110

0.41%EUR 4.88

Ramsay Generale de Sante SA

Ramsay Generale de Sante SA Valor: 1247709

Annual Return

-50%0%+50%

Risk level

110

-0.20%EUR 9.86

MedNation AG

MedNation AG Valor: 331107

Annual Return

-50%0%+50%

Risk level

110

1.71%EUR 3.56

Insmed Inc

Insmed Inc Valor: 12614415

Annual Return

-50%0%+50%

Risk level

110

5.07%USD 140.01

SIX

FactSet

Clearbit

Logos provided by Clearbit